Ensoma Announces First Patient Dosed in Phase 1/2 Clinical Trial of EN-374 for Treatment of X-CGD

Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, today announced that the first patient has been dosed in the company’s ...

Inside the lab hunting for Disease X – and the next pandemic

Inside the lab hunting for Disease X – and the next pandemic - ON THE GROUND: As rich countries turn their back on foreign ...
AOL

'Disease X' Sparks Fears as New Virus Could 'Wipe Out' Society With 'High Mortality Rate' — 'Will Make Covid Pandemic Look Mild'

COVID-19 brought the world to a standstill in 2020, changing the way we all live, but now experts fear a new, deadlier virus may be on the way, RadarOnline.com can reveal. A new documentary, titled ...
Hosted on MSN

'Disease X' fears as virus with '70% mortality rate' could bring humanity to halt

The Covid-19 pandemic left a lasting mark on the world, killing an estimated seven million people worldwide. Experts worry that it might have been just a "warning shot" with even deadlier pandemics to ...
Medscape

Can an Extra X Chromosome Amplify Autoimmune Disease Risk?

Extra X chromosomes significantly increase the risk for systemic lupus erythematosus (SLE) and Sjögren disease, with the prevalence of these conditions being higher among patients with Klinefelter and ...